OrganOx Completes $142 Million Equity Financing Led by HealthQuest Capital
OrganOx Ltd., a leading organ medical technology company and a prominent name in organ preservation technologies, has fulfilled a goal recently and is the big news worldwide. It has completed a $142 million equity in primary and secondary finance round superheaded by HealthQuest Capital, so the growth opportunities in metra® platform technology are accelerated. HealthQuest is…